Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2022-01-25 00:00:00 ET · period of report 2022-01-25 · accession 0001209191-22-004860 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-25 | 2022-01-25 | CRBU | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +60.0K | 65.0K | +1,200% | $0 |
| D | 2022-01-25 | 2022-01-25 | CRBU | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +161.2K | 161.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-01-25 | A | A | 60,000 | $0.00 | 65,000 | D | — | — | (F1) This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on January 18, 2023, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. |
| 2 | Derivative | Option to purchase common stock | 2022-01-25 | A | A | 161,250 | $0.00 | 161,250 | D | $10.64 · — to 2032-01-24 | 161,250 Common stock | (F2) 1/4th of the shares subject to this option will vest on January 18, 2023 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. |